<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-148138" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chronic Venous Insufficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Annapoorna</given-names>
          </name>
          <aff>Kansas City School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zahra</surname>
            <given-names>Farah</given-names>
          </name>
          <aff>Northwestern Mchenry/RFMUS</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Annapoorna Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Farah Zahra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-148138.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chronic venous disease (CVD) comprises a broad spectrum of venous disorders characterized by severely impaired blood return in the lower extremities. Due to underestimating the scope and significance and failing to fully recognize the various venous diseases, it is generally overlooked by healthcare professionals. Varicose veins afflict more than 25 million people in the United States, and more than 6 million harbors severe venous disease, making CVD a prevalent health condition. The most common signs of CVD are telangiectases, reticular veins, varicose veins, and venous ulcerations. Chronic venous insufficiency (CVI) stems from persistent ambulatory venous hypertension. Frequent causes of venous hypertension include insufficient muscular pumping, malfunctioning venous valves (reflux), and venous obstruction, which leads to a cascade of morphological, physiological, and histologic abnormalities. This activity discusses the etiology, risk factors, pathophysiology, clinical manifestations, and management of CVD and emphasizes the importance of the interprofessional team in managing these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the etiology and risk factors of chronic venous disease.</p></list-item><list-item><p>Review the pathophysiology of chronic venous disease.</p></list-item><list-item><p>Describe the clinical manifestations and summarize the management of chronic venous disease.</p></list-item><list-item><p>Summarize interprofessional team approaches to enhance care and optimize outcomes for chronic venous disease patients.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=148138&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=148138">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-148138.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chronic venous disease (CVD) is defined by morphological and functional abnormalities of the venous system that primarily affect the lower extremities and present as leg heaviness/achiness, edema, telangiectasia, and varicose veins. Persistent ambulatory venous hypertension and the ensuing inflammation are the pathophysiological alterations that underlie CVD. It is estimated that over 2.5 million individuals in the United States experience CVD; of them, approximately 20% develop venous ulcers.<xref ref-type="bibr" rid="article-148138.r1">[1]</xref></p>
        <p>CVD and chronic venous ulcers are associated with a poor prognosis and impede the capacity to participate in occupational and social activities, resulting in diminished quality of life and financial limitations. Approximately 2 million workdays per year are lost due to venous ulcer-related disability, and more than 12 percent of workers with venous ulcers retire prematurely as a result.<xref ref-type="bibr" rid="article-148138.r2">[2]</xref>&#x000a0;</p>
        <p>The financial burden of venous ulcers on the healthcare system is readily evident, with an estimated $1 billion spent annually in the United States on chronic wound treatment, equating to $3 billion annually for venous ulcer care.<xref ref-type="bibr" rid="article-148138.r3">[3]</xref></p>
      </sec>
      <sec id="article-148138.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of the chronic venous disease remains elusive. It appears to have a hereditary component since genetic disorders like Klippel-Trenaunay and Parkes-Weber are known to cause CVD.<xref ref-type="bibr" rid="article-148138.r4">[4]</xref>&#x000a0;The risk factors associated with CVD are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Age</p>
          </list-item>
          <list-item>
            <p>Sex</p>
          </list-item>
          <list-item>
            <p>Overweight</p>
          </list-item>
          <list-item>
            <p>Use of oral contraceptives</p>
          </list-item>
          <list-item>
            <p>Tobacco use</p>
          </list-item>
          <list-item>
            <p>Pregnancy</p>
          </list-item>
          <list-item>
            <p>Family history of varicose veins</p>
          </list-item>
          <list-item>
            <p>A history of deep vein thrombosis</p>
          </list-item>
          <list-item>
            <p>History of thrombophlebitis</p>
          </list-item>
          <list-item>
            <p>History of the leg injury</p>
          </list-item>
          <list-item>
            <p>Prolonged standing or sitting</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-148138.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The risk of chronic venous disease increases with age and has a 3&#x000a0;to 1 female predominance.<xref ref-type="bibr" rid="article-148138.r5">[5]</xref>&#x000a0;The Framingham research found an annual incidence of 2.6% in women and 1.9% in males.<xref ref-type="bibr" rid="article-148138.r6">[6]</xref>&#x000a0;Varicose veins are more widespread in industrialized and developed nations than underdeveloped ones.</p>
      </sec>
      <sec id="article-148138.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The peripheral venous system serves as a blood reserve and a channel for returning blood to the heart. The patency of blood veins, valves, and muscle pumps is necessary to function the venous system properly. To return to the central circulation, blood must travel against gravity and other pressures in the upright position. The veins of the lower extremities are classified as superficial (above the facial muscle layer), deep (below the fascial layer), and perforator.<xref ref-type="bibr" rid="article-148138.r7">[7]</xref>&#x000a0;</p>
        <p>The superficial venous system consists of the great saphenous vein (GSV) and small saphenous vein, in addition to several accessory veins. Deep veins are made up of axial veins. Perforating veins traverse the fascial layer connecting superficially to deep veins. Throughout the deep and superficial veins are a number of one-way bicuspid valves that allow blood to travel toward the heart while preventing it from returning to the feet.<xref ref-type="bibr" rid="article-148138.r5">[5]</xref>&#x000a0;</p>
        <p>Multiple processes contribute to the development of venous disease wherein&#x000a0;venous pressure is elevated and blood return is impeded, such as valvular incompetence, thrombotic or non-thrombotic venous blockage, or extrinsic&#x000a0;compression of the veins. These variables are worsened by dysfunctional muscular pumps, particularly in the calf muscles.&#x000a0;These trajectories result in global or localized venous hypertension, especially when standing or walking. Persistent venous hypertension can result in hyperpigmentation of the skin, lipodermatosclerosis of the subcutaneous tissue, and, eventually, ulceration.&#x000a0;</p>
        <p>Preexisting vascular wall weakness, superficial phlebitis, or severe venous distention due to hormonal influences might result in a weakened superficial veins valve. In contrast,&#x000a0;deep vein thrombosis or venous stenosis may cause dysfunction of the deep veins valve.<xref ref-type="bibr" rid="article-148138.r5">[5]</xref></p>
      </sec>
      <sec id="article-148138.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The major clinical manifestations of chronic venous insufficiency (CVI) are dilated&#x000a0;veins such as telangiectasias, reticular veins, varicose veins, leg&#x000a0;edema, pain/achiness/heaviness, and&#x000a0;skin alterations. Varicose veins are dilated superficial veins that get increasingly convoluted and larger over time.</p>
        <p>The edema originates in the peri malleolar region, progresses up the leg in a dependent manner, is pitting in nature, and spares the forefoot. Deep venous system occlusion may cause venous claudication, which improves with rest. Cutaneous alterations include skin darkening due to hemosiderin deposition and eczematous dermatitis. Lipodermatosclerosis is&#x000a0;a fibrotic process involving the dermis and subcutaneous fat.</p>
        <p>Venous ulcers most commonly occur along the medial surface above the malleolus. There is an increased risk of cellulitis and superficial thrombophlebitis. An international consensus conference developed the Clinical, Etiology, Anatomic, and Pathophysiology (CEAP) classification to improve consistency in reporting, diagnosis, and treating CVI.<xref ref-type="bibr" rid="article-148138.r8">[8]</xref>&#x000a0;In addition to complementing the CEAP, the revised venous clinical severity score better reflects the CVI severity and has extended clinical utility.<xref ref-type="bibr" rid="article-148138.r9">[9]</xref>&#x000a0;It aids in determining the efficacy of CVD treatments. Consequently, it is recommended for routine clinical usage (1B grade).<xref ref-type="bibr" rid="article-148138.r10">[10]</xref><xref ref-type="bibr" rid="article-148138.r11">[11]</xref>&#x000a0;</p>
        <p>
<bold>CEAP Classification and Description</bold>
</p>
        <p>
<bold>Clinical Classification</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>C0-No visible or palpable signs of venous disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>C1-Telengiectases or reticular veins&#x000a0;</p>
          </list-item>
          <list-item>
            <p>C2-Varicose veins&#x000a0;</p>
          </list-item>
          <list-item>
            <p>C3-Edema&#x000a0;</p>
          </list-item>
          <list-item>
            <p>C4a-Pigmentation and/or eczema&#x000a0;</p>
          </list-item>
          <list-item>
            <p>C4b-Lipodermatosclerosis and/or atrophy</p>
          </list-item>
          <list-item>
            <p>C5-Healed venous ulcer</p>
          </list-item>
          <list-item>
            <p>C6-Active venous ulcer&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Etiologic Classification</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Ec-Congenital&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ep-Primary&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Es-Secondary&#x000a0;</p>
          </list-item>
          <list-item>
            <p>En-No venous etiology identified&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Anatomic Classification</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>As-superficial veins&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ap-Perforator veins</p>
          </list-item>
          <list-item>
            <p>Ad-Deep veins&#x000a0;</p>
          </list-item>
          <list-item>
            <p>An-No venous location identified&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Pathophysiologic Classification</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Pr-Reflux&#x000a0;</p>
          </list-item>
          <list-item>
            <p>P0-Obstruction</p>
          </list-item>
          <list-item>
            <p>Pr/o-Reflux and obstruction&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pn-No venous pathophysiology identifiable</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-148138.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Accurately diagnosing chronic venous disease requires a thorough history and physical examination, supplemented by noninvasive testing. Invasive testing is typically reserved for cases where surgery is being considered. In an upright position, the skin should be inspected for conspicuous, dilated veins such as telangiectasia, reticular veins, or varicose veins, and their distribution should also be noted. Additionally, active or healed ulcers, hyperpigmentation, stasis dermatitis, atrophie Blanche, or lipodermatosclerosis should be evaluated. The standard tourniquet test (e.g., the Brodie-Trendelenburg) can be conducted at the bedside to differentiate between deep and superficial reflux. In addition, a handheld continuous-wave Doppler may be used to aid in bedside assessment.<xref ref-type="bibr" rid="article-148138.r12">[12]</xref></p>
        <p>Currently, venous duplex imaging is the most popular and recommended method for assessing the etiology and anatomy and diagnosing CVD. Venous duplex imaging combines B-mode imaging of the deep and superficial veins with pulsed Doppler assessment of flow direction using provocative methods.<xref ref-type="bibr" rid="article-148138.r5">[5]</xref>&#x000a0;</p>
        <p>Air plethysmography (APG) can assess all potential pathophysiologic processes of CVI, such as reflux, obstruction, and muscle pump failure.<xref ref-type="bibr" rid="article-148138.r13">[13]</xref>&#x000a0;Abnormal venous filling indices correlate with the severity of CVI, provide information on several features of global venous function, and can be utilized for intervention selection and response evaluation.<xref ref-type="bibr" rid="article-148138.r14">[14]</xref><xref ref-type="bibr" rid="article-148138.r15">[15]</xref>&#x000a0;</p>
        <p>When a venous duplex fails to provide conclusive evidence on the etiology of CVI, APG may be therapeutically beneficial. Computed tomography and magnetic resonance venography require intravenous contrast material and are particularly useful for evaluating proximal veins and their surrounding structures to assess for intrinsic and extrinsic compression. Before intervention is advised, these procedures may be utilized to characterize complex venous anatomy, such as an iliofemoral venous blockage.<xref ref-type="bibr" rid="article-148138.r5">[5]</xref>&#x000a0;</p>
        <p>Photoplethysmography, strain gauge plethysmography, and foot volumetry are other noninvasive diagnostic procedures.</p>
        <p>Invasive testing includes a) contrast venography is most beneficial to identify reflux in the common femoral vein and at the saphenofemoral junction and may be used in cases of venous reconstruction; b) intravascular ultrasound is a catheter-based ultrasound probe and is employed to visualize periluminal vascular anatomy to detect venous obstruction or stenosis;&#x000a0;&#x000a0;c) Ambulatory venous pressure measurement is the gold standard for determining the hemodynamics of CVI;&#x000a0;it requires insertion of a needle into the dorsal foot vein and connecting it to a pressure transducer.<xref ref-type="bibr" rid="article-148138.r16">[16]</xref></p>
        <p>Despite its value in determining CVI's severity and clinical outcomes, it is rarely used because of its invasive nature and alternative diagnostic modalities.</p>
      </sec>
      <sec id="article-148138.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Conservative treatments, such as compression stockings, are the cornerstone and initial step of CVI management. Compression treatment aims to provide graduated external compression to the lower extremities and counteract the hydrostatic pressures of venous hypertension. Available compression garments consist of graded elastic compressive stockings, gauze boots, layered bandaging, and adjustable compression garments.<xref ref-type="bibr" rid="article-148138.r5">[5]</xref>&#x000a0;</p>
        <p>The tension between 30- and 50-mm Hg is believed to produce considerable improvement in pain, edema, and pigmentation with a compliance of 70 and 80%.<xref ref-type="bibr" rid="article-148138.r17">[17]</xref>&#x000a0;It is also helpful in both healing ulcers and preventing their recurrences. Obesity is a well-established risk factor for developing&#x000a0;CVI and its associated consequences; thus, maintaining an optimal body weight may improve CVI symptoms. It has been proven that weight loss following bariatric surgery improves CVI symptoms, including edema and ulceration.<xref ref-type="bibr" rid="article-148138.r18">[18]</xref></p>
        <p><bold>Skin and wound care:</bold> Advanced CVI may affect skin integrity; therefore, it is crucial to maintain skin health and avoid infection. Topical moisturizers, commonly containing lanolin, minimize skin fissuring and disintegration. Topical steroids may be used to treat stasis dermatitis. Bacterial overgrowth may occur with venous ulcers; hence diligent wound care is needed to limit infection. A range of hydrocolloids and foam dressings can reduce wound fluid drainage and skin maceration.<xref ref-type="bibr" rid="article-148138.r19">[19]</xref>&#x000a0;Biologic skin replacements derived from tissue engineering have been used to treat ulcers with some effectiveness, although silver-impregnated dressing has been controversial.</p>
        <p><bold>Sclerotherapy:</bold> Sclerotherapy is beneficial in treating telangiectasias, reticular veins, varicose veins (1-4 mm diameter), and veins with reflux. It can be used as a primary or in combination with other treatments. Sclerosing agents include the hypertonic solution of sodium chloride (23.4%), polidocanol, sodium iodide, chromated glycerin, sodium tetradecyl sulfate, and sodium morrhuate. For veins with a lower diameter, the sclerosing agent must often be diluted to prevent tissue irritation and necrosis. Polidocanol is superior to normal saline, eliminating incompetent varicose veins and enhancing venous hemodynamics.<xref ref-type="bibr" rid="article-148138.r20">[20]</xref>&#x000a0;</p>
        <p>Darkening of the surrounding skin because of hemosiderin degradation is a common side effect of sclerotherapy, which may be mitigated by microthrombectomy, which involves the expulsion of the thrombus.</p>
        <p><bold>Endovenous ablative therapy</bold>: Ablation of incompetent veins utilizes thermal energy through radiofrequency or laser. This procedure is often utilized for GSV reflux as an alternative to stripping.&#x000a0;The heat produced induces local thermal damage to the vein wall, leading to thrombosis and fibrosis. Radiofrequency ablation of the GSV results in complete obliteration in 85% of patients after two years. Laser therapy with either an 810-nm or 940-nm diode has shown outstanding outcomes, with saphenous vein obliteration in 93% of patients at two years.<xref ref-type="bibr" rid="article-148138.r21">[21]</xref>&#x000a0;</p>
        <p>Both radiofrequency and laser treatments are administered under tumescent anesthesia to avoid skin burns, minimize discomfort, and facilitate a speedier return to regular activities. Deep venous thrombosis and pulmonary embolism remain, although seldom, the possible complications of ablation.</p>
        <p><bold>Endovenous deep system therapy</bold>: For iliac vein stenosis and occlusion, endovascular stenting has superseded surgical techniques such as cross-femoral venous bypass or prosthetic iliac vein reconstructions. Close monitoring is recommended to ensure that stent patency is maintained since in-stent restenosis or occlusion can occur in individuals with thrombotic illness; however, restenosis is uncommon (5%).<xref ref-type="bibr" rid="article-148138.r5">[5]</xref>&#x000a0;The efficacy of iliac stenting seems to be lasting, with 85 to 90 percent of patients being free of recurrent ulcers after five years.<xref ref-type="bibr" rid="article-148138.r22">[22]</xref></p>
        <p><bold>Surgical management</bold>: In individuals who do not respond to pharmacological or endovenous therapy, surgical surgery for CVI may be considered in addition to compression stockings. Specifically for individuals with persistent discomfort and disability, recurrent varicose veins, inability to cooperate with compression treatment, and chronic non-healing venous ulcers.</p>
        <p>The prospective method is contingent upon the underlying pathophysiologic processes and afflicted vein area. Ligation and stripping have been shown to enhance venous hemodynamics, alleviate pain and promote ulcer healing. The excision of GSV with high ligation at the saphenofemoral junction is sustainable and applicable to all CEAP classes with GSV reflux. Venous valve reconstruction procedures include valvuloplasty, transposition, transplant, cryopreserved vein valve allografts, and neo-valve construction.</p>
      </sec>
      <sec id="article-148138.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute deep vein thrombosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
          <list-item>
            <p>Cirrhosis</p>
          </list-item>
          <list-item>
            <p>Renal failure</p>
          </list-item>
          <list-item>
            <p>Endocrine disorders such as hypothyroidism</p>
          </list-item>
          <list-item>
            <p>Medication side effects, e.g., calcium channel blockers, NSAIDs, oral hypoglycemic agents</p>
          </list-item>
          <list-item>
            <p>Lymphedema</p>
          </list-item>
          <list-item>
            <p>Lipedema</p>
          </list-item>
          <list-item>
            <p>Ruptured popliteal cyst</p>
          </list-item>
          <list-item>
            <p>Soft tissue hematoma/mass</p>
          </list-item>
          <list-item>
            <p>Exertional compartment syndrome</p>
          </list-item>
          <list-item>
            <p>Gastrocnemius tear</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-148138.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Untreated chronic venous disease imposes the following complications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic venous ulceration&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Deep vein thrombosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recurrent cellulitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lipodermatosclerosis</p>
          </list-item>
          <list-item>
            <p>Secondary lymphedema&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Stasis dermatitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic pain/discomfort</p>
          </list-item>
          <list-item>
            <p>Superficial thrombophlebitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Secondary hemorrhage&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Atrophie blanche</p>
          </list-item>
          <list-item>
            <p>Ankle joint stiffness from chronic scarring</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-148138.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The patient should be instructed on the proper and effective use of compression stockings, emphasizing compliance and the use of the optimal tension gradient. Compression stockings alone may ease discomfort, edema, and venous distention, aid venous ulcer healing and prevent recurrences. In addition, the patient should be instructed to preserve skin integrity by regularly checking the skin for breakdowns or infections and diligently applying moisturizer to prevent fissuring. Also, patients should be advised to elevate their legs to minimize swelling. Finally, avoid extended periods of standing or sitting.</p>
        <p>Patients should be encouraged to maintain ideal body weight and identify any obstacles that hamper losing weight, such as psychiatric illnesses such as depression, anxiety, eating disorders, medications causing weight gain, or mobility issues such as knee osteoarthritis. Address these concerns accordingly by an appropriate specialist referral or patient education. In addition, patients should be made aware that chronic venous disease is a long-term health concern. Hence regular follow-up with the providers and compliance with medical treatment plans are&#x000a0;essential for preventing its consequences.</p>
      </sec>
      <sec id="article-148138.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The optimum treatment of chronic venous disease requires an interprofessional&#x000a0;healthcare team approach. This group must include a primary care physician, vascular and general surgery experts, wound care nurses, physical and occupational therapists, dieticians, a weight management team, bariatric surgery, and a pharmacist.</p>
        <p>An early diagnosis, treatment plan, and referral to a specialist are crucial to&#x000a0;effectively managing chronic venous disease. Primary care providers should conduct diagnostic testing to rule out other causes of lower limb edema and avoid prescribing medications, such as calcium channel blockers and nonsteroidal anti-inflammatory medicines, that may exacerbate the illness. The pharmacist may be able to review the patient's drugs and aid in the development of an alternate treatment plan to prevent the condition from worsening. Wound care nurses and occupational therapists may aid in treating venous ulcers.</p>
        <p>Chronic venous ulcers that do not heal or disease recurrence should demand referral to vascular and general surgery experts. To avoid disease progression and recurrence, patients should be closely followed. Patients who fail conservative or pharmacological approaches to losing weight should be referred to a bariatric surgeon, as losing weight/maintaining optimal weight is crucial in managing chronic venous disease.</p>
      </sec>
      <sec id="article-148138.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=148138&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=148138">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/chronic-venous-insufficiency-backup-of-blood-in-the-leg-veins/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=148138">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/148138/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=148138">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-148138.s14">
        <title>References</title>
        <ref id="article-148138.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhodes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gloviczki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Canton</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Rooke</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Lindsey</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Factors affecting clinical outcome following endoscopic perforator vein ablation.</article-title>
            <source>Am J Surg</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>176</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-7</page-range>
            <pub-id pub-id-type="pmid">9737624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Da Silva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Batalheiro</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[The importance of chronic venous insufficiency. Various preliminary data on its medico-social consequences].</article-title>
            <source>Phlebologie</source>
            <year>1992</year>
            <season>Nov-Dec</season>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>439</fpage>
            <page-range>439-43</page-range>
            <pub-id pub-id-type="pmid">1302319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierce</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Mustoe</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Pharmacologic enhancement of wound healing.</article-title>
            <source>Annu Rev Med</source>
            <year>1995</year>
            <volume>46</volume>
            <fpage>467</fpage>
            <page-range>467-81</page-range>
            <pub-id pub-id-type="pmid">7598479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noel</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Gloviczki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cherry</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Rooke</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Stanson</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Driscoll</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment of venous malformations in Klippel-Tr&#x000e9;naunay syndrome.</article-title>
            <source>J Vasc Surg</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>840</fpage>
            <page-range>840-7</page-range>
            <pub-id pub-id-type="pmid">11054214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eberhardt</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Raffetto</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Chronic venous insufficiency.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Jul</month>
            <day>22</day>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>333</fpage>
            <page-range>333-46</page-range>
            <pub-id pub-id-type="pmid">25047584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brand</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Dannenberg</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Abbott</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of varicose veins: the Framingham Study.</article-title>
            <source>Am J Prev Med</source>
            <year>1988</year>
            <season>Mar-Apr</season>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>96</fpage>
            <page-range>96-101</page-range>
            <pub-id pub-id-type="pmid">3395496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caggiati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bergan</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Gloviczki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jantet</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wendell-Smith</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Partsch</surname>
                <given-names>H</given-names>
              </name>
              <collab>International Interdisciplinary Consensus Committee on Venous Anatomical Terminology</collab>
            </person-group>
            <article-title>Nomenclature of the veins of the lower limbs: an international interdisciplinary consensus statement.</article-title>
            <source>J Vasc Surg</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>416</fpage>
            <page-range>416-22</page-range>
            <pub-id pub-id-type="pmid">12170230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porter</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Moneta</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease.</article-title>
            <source>J Vasc Surg</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>635</fpage>
            <page-range>635-45</page-range>
            <pub-id pub-id-type="pmid">7707568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasquez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rabe</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>McLafferty</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Shortell</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Marston</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Gillespie</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meissner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Rutherford</surname>
                <given-names>RB</given-names>
              </name>
              <collab>American Venous Forum Ad Hoc Outcomes Working Group</collab>
            </person-group>
            <article-title>Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group.</article-title>
            <source>J Vasc Surg</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>1387</fpage>
            <page-range>1387-96</page-range>
            <pub-id pub-id-type="pmid">20875713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gloviczki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Comerota</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Dalsing</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Eklof</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Gillespie</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Gloviczki</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lohr</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>McLafferty</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Meissner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Padberg</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Passman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Raffetto</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Vasquez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wakefield</surname>
                <given-names>TW</given-names>
              </name>
              <collab>Society for Vascular Surgery</collab>
              <collab>American Venous Forum</collab>
            </person-group>
            <article-title>The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.</article-title>
            <source>J Vasc Surg</source>
            <year>2011</year>
            <month>May</month>
            <volume>53</volume>
            <issue>5 Suppl</issue>
            <fpage>2S</fpage>
            <page-range>2S-48S</page-range>
            <pub-id pub-id-type="pmid">21536172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kakkos</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Matsagas</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Lazarides</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Robless</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Belcaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Geroulakos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Validation of the new venous severity scoring system in varicose vein surgery.</article-title>
            <source>J Vasc Surg</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>224</fpage>
            <page-range>224-8</page-range>
            <pub-id pub-id-type="pmid">12891101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Folse</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Directional flow detection for localizing venous valvular incompetency.</article-title>
            <source>Surgery</source>
            <year>1970</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>114</fpage>
            <page-range>114-21</page-range>
            <pub-id pub-id-type="pmid">5409849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nicolaides</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Szendro</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Venous reflux: quantification and correlation with the clinical severity of chronic venous disease.</article-title>
            <source>Br J Surg</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>352</fpage>
            <page-range>352-6</page-range>
            <pub-id pub-id-type="pmid">3359149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillespie</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Cordts</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Hartono</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Woodson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Obi-Tabot</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>LaMorte</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Menzoian</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>The role of air plethysmography in monitoring results of venous surgery.</article-title>
            <source>J Vasc Surg</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>674</fpage>
            <page-range>674-8</page-range>
            <pub-id pub-id-type="pmid">1433653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Owens</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Carlin</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Criado-Pallares</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Passman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Keagy</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Marston</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>The value of air plethysmography in predicting clinical outcome after surgical treatment of chronic venous insufficiency.</article-title>
            <source>J Vasc Surg</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>961</fpage>
            <page-range>961-8</page-range>
            <pub-id pub-id-type="pmid">11054228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicolaides</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Zukowski</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>The value of dynamic venous pressure measurements.</article-title>
            <source>World J Surg</source>
            <year>1986</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>919</fpage>
            <page-range>919-24</page-range>
            <pub-id pub-id-type="pmid">3798938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Motykie</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Caprini</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Arcelus</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Reyna</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Overom</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mokhtee</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency.</article-title>
            <source>Dermatol Surg</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-20</page-range>
            <pub-id pub-id-type="pmid">10037516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugerman</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Sugerman</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Wolfe</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kellum</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schweitzer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>DeMaria</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease.</article-title>
            <source>Ann Surg</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>234</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-6</page-range>
            <pub-id pub-id-type="pmid">11460821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karlsmark</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Agerslev</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Bendz</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Roed-Petersen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers.</article-title>
            <source>J Wound Care</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>9</issue>
            <fpage>351</fpage>
            <page-range>351-4</page-range>
            <pub-id pub-id-type="pmid">14601228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kahle</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Leng</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of sclerotherapy in varicose veins-- prospective, blinded, placebo-controlled study.</article-title>
            <source>Dermatol Surg</source>
            <year>2004</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>723</fpage>
            <page-range>723-8; discussion 728</page-range>
            <pub-id pub-id-type="pmid">15099314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Khilnani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zimmet</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Endovenous laser treatment of saphenous vein reflux: long-term results.</article-title>
            <source>J Vasc Interv Radiol</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>991</fpage>
            <page-range>991-6</page-range>
            <pub-id pub-id-type="pmid">12902556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148138.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raju</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Darcey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Negl&#x000e9;n</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Unexpected major role for venous stenting in deep reflux disease.</article-title>
            <source>J Vasc Surg</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>401</fpage>
            <page-range>401-8; discussion 408</page-range>
            <pub-id pub-id-type="pmid">20006920</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
